These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37106218)

  • 1. Impact of ABO incompatibility and early antibody-mediated rejection on chronic antibody-mediated rejection in kidney transplant patients.
    Heo GY; Jang Y; Choi H; Kim YC; Han SS; Kim HW; Lee J; Huh KH; Kim BS; Yang J
    J Nephrol; 2023 Dec; 36(9):2571-2580. PubMed ID: 37106218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors.
    Tasaki M; Saito K; Nakagawa Y; Imai N; Ito Y; Yoshida Y; Ikeda M; Ishikawa S; Narita I; Takahashi K; Tomita Y
    Int J Urol; 2019 Dec; 26(12):1128-1137. PubMed ID: 31587389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation.
    Maenosono R; Unagami K; Kakuta Y; Furusawa M; Okumi M; Azuma H; Ishida H; Tanabe K
    Int J Urol; 2019 Dec; 26(12):1114-1120. PubMed ID: 31522467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
    Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
    Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
    Ashimine S; Watarai Y; Yamamoto T; Hiramitsu T; Tsujita M; Nanmoku K; Goto N; Takeda A; Katayama A; Uchida K; Kobayashi T
    Kidney Int; 2014 Feb; 85(2):425-30. PubMed ID: 23945498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of blood group antibodies in ABO-incompatible living-donor kidney transplantation.
    Sugiyama K; Hyodo Y; Aikawa A
    Int J Urol; 2015 Oct; 22(10):931-6. PubMed ID: 26108258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Findings of graft biopsy specimens within 90 days after ABO blood group incompatible living donor kidney transplantation compared with ABO-identical and non-identical transplantation.
    Ushigome H; Okamoto M; Koshino K; Nobori S; Okajima H; Masuzawa N; Urasaki K; Yoshimura N
    Clin Transplant; 2010 Jul; 24 Suppl 22():16-21. PubMed ID: 20590688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO-incompatible kidney transplantation using both A2 and non-A2 living donors.
    Gloor JM; Lager DJ; Moore SB; Pineda AA; Fidler ME; Larson TS; Grande JP; Schwab TR; Griffin MD; Prieto M; Nyberg SL; Velosa JA; Textor SC; Platt JL; Stegall MD
    Transplantation; 2003 Apr; 75(7):971-7. PubMed ID: 12698082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single fixed low-dose rituximab as induction therapy suppresses de novo donor-specific anti-HLA antibody production in ABO compatible living kidney transplant recipients.
    Tomita Y; Iwadoh K; Ogawa Y; Miki K; Kato Y; Kai K; Sannomiya A; Koyama I; Kitajima K; Nakajima I; Fuchinoue S
    PLoS One; 2019; 14(10):e0224203. PubMed ID: 31644555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation.
    Schwartz J; Stegall MD; Kremers WK; Gloor J
    Transplantation; 2006 Jul; 82(2):155-63. PubMed ID: 16858274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants.
    Pandey P; Setya D; Sinha VK; Devra AK; Bhatt AP; Pande A; Kumar P; Singh MK; Ranjan S
    J Clin Apher; 2021 Jun; 36(3):299-312. PubMed ID: 33316838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations.
    Ko Y; Kim JY; Kim SH; Kim DH; Lim SJ; Shin S; Kim YH; Jung JH; Park SK; Kwon H; Han DJ
    Ann Transplant; 2020 Oct; 25():e927420. PubMed ID: 33020465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoagglutinin adsorption in ABO-incompatible transplantation.
    Genberg H; Kumlien G; Wennberg L; Tydén G
    Transfus Apher Sci; 2010 Oct; 43(2):231-5. PubMed ID: 20667787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABO-incompatible kidney transplantation as a renal replacement therapy-A single low-volume center experience in Japan.
    Kosoku A; Uchida J; Nishide S; Kabei K; Shimada H; Iwai T; Kuwabara N; Maeda K; Naganuma T; Kumada N; Takemoto Y; Ishihara T; Shintani A; Nakatani T
    PLoS One; 2018; 13(12):e0208638. PubMed ID: 30596663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of desensitization in human leukocyte antigen- and ABO-incompatible living donor kidney transplantation: a single-center experience in more than 100 patients.
    Al Meshari K; Pall A; Chaballout A; El Gamal H; Al Mana H; Humaidan H; Alzayer F; Al Talhi M
    Transplant Proc; 2013 May; 45(4):1423-6. PubMed ID: 23726587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
    Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
    Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO-incompatible pediatric kidney transplantation without antibody removal.
    Kawamura T; Hamasaki Y; Takahashi Y; Hashimoto J; Kubota M; Muramatu M; Itabashi Y; Hyodo Y; Ohashi Y; Aikawa A; Sakai K; Shishido S
    Pediatr Nephrol; 2020 Jan; 35(1):95-102. PubMed ID: 31673829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies.
    Masutani K; Tsuchimoto A; Kurihara K; Okabe Y; Kitada H; Okumi M; Tanabe K; Nakamura M; Kitazono T; Tsuruya K;
    Transplantation; 2017 Jun; 101(6):1416-1422. PubMed ID: 27391195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation.
    Barnett AN; Manook M; Nagendran M; Kenchayikoppad S; Vaughan R; Dorling A; Hadjianastassiou VG; Mamode N
    Transpl Int; 2014 Feb; 27(2):187-96. PubMed ID: 24188566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO-incompatible living donor kidney transplantation without post-transplant therapeutic plasma exchange.
    Yabu JM; Fontaine MJ
    J Clin Apher; 2015 Dec; 30(6):340-6. PubMed ID: 25739580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.